Nanomedicine: Dynamic integration of nanotechnology with biomedical science

Nanomedicine: A Systems Engineering Approach

Volumn , Issue , 2009, Pages 2-39

  Lee, Ki Bum ^a   Solanki, Aniruddh ^a   Kim, John D ^a   Jung, Jongjin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880187286     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4032/9789814241373     Document Type: Chapter

References (183)

1. P. Alivisatos, "The use of nanocrystals in biological detection," Nature Biotechnology, 22, 47-52 (2004).
2. W. C.W. Chan and S. M. Nie, "Quantum dot bioconjugates for ultrasensitive nonisotopic detection," Science, 281, 2016-2018 (1998).
3. D. S. Ginger, H. Zhang, and C. A. Mirkin, "The evolution of dip-pen nanolithography," Angewandte Chemie-International Edition, 43, 30-45 (2004).
4. S. G. Penn, L. He, and M. J. Natan, "Nanoparticles for bioanalysis," Current Opinion in Chemical Biology, 7, 609-615 (2003).
5. A. P. Alivisatos, P. F. Barbara, A.W. Castleman, J. Chang, D. A. Dixon, M. L. Klein, G. L. McLendon, J. S. Miller, M. A. Ratner, P. J. Rossky, S. I. Stupp, and M. E. Thompson, "From molecules to materials: Current trends and future directions," Advanced Materials, 10, 1297-1336 (1998).
6. R. Elghanian, J. J. Storhoff, R. C. Mucic, R. L. Letsinger, and C. A. Mirkin, "Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles," Science, 277, 1078-1081 (1997).
7. C. A. Mirkin, R. L. Letsinger, R. C. Mucic, and J. J. Storhoff, "ADNAbased method for rationally assembling nanoparticles into macroscopic materials," Nature, 382, 607-609 (1996).
8. J. J. Storhoff and C. A. Mirkin, "Programmed materials synthesis with DNA," Chemical Reviews, 99, 1849-1862 (1999).
9. C. M. Niemeyer, "Nanoparticles, proteins, and nucleic acids: Biotechnology meets materials science," Angewandte Chemie-International Edition, 40, 4128-4158 (2001).
10. C. M. Niemeyer, "Nanotechnology: Tools for the biomolecular engineer," Science, 297, 62-63 (2002).
11. Y. Weizmann, F. Patolsky, O. Lioubashevski, and I. Willner, "Magnetomechanical detection of nucleic acids and telomerase activity in cancer cells," Journal of the American Chemical Society, 126, 1073-1080 (2004).
12. I. Willner, "Photoswitchable biomaterials: En route to optobioelectronic systems," Accounts of Chemical Research, 30, 347-356 (1997).
13. I. Willner, "Protein hinges for bioelectronics - Changes in protein conformation have been exploited to create chemoresponsive bioelectronic sensors," Nature Biotechnology, 19, 1023-1024 (2001).
14. I. Willner, "Biomaterials for sensors, fuel cells, and circuitry," Science, 298, 2407-2408 (2002).
15. N. L. Rosi and C. A. Mirkin, "Nanostructures in biodiagnostics," Chemical Reviews, 105, 1547-1562 (2005).
16. M. Bruchez, M. Moronne, P. Gin, S. Weiss, andA. P. Alivisatos, "Semiconductor nanocrystals as fluorescent biological labels," Science, 281, 2013-2016 (1998).
17. S. J. Clarke, C. A. Hollmann, Z. J. Zhang, D. Suffern, S. E. Bradforth, N. M. Dimitrijevic, W. G. Minarik, and J. L. Nadeau, "Photophysics of dopamine-modified quantumdots and effects on biological systems," Nature Materials, 5, 409-417 (2006).
18. E. T. Ahrens, R. Flores, H. Y. Xu, and P. A. Morel, "In vivo imaging platform for tracking immunotherapeutic cells," Nature Biotechnology, 23, 983-987 (2005).
19. T.A. Byassee, W. C.W. Chan, and S.M. Nie, "Probing single molecules in single living cells," Analytical Chemistry, 72, 5606-5611 (2000).
20. J. K. Jaiswal, H. Mattoussi, J. M. Mauro, and S. M. Simon, "Long-term multiple color imaging of live cells using quantum dot bioconjugates," Nature Biotechnology, 21, 47-51 (2003).
21. X. Y. Wu, H. J. Liu, J. Q. Liu, K. N. Haley, J. A. Treadway, J. P. Larson, N. F. Ge, F. Peale, and M. P. Bruchez, "Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots," Nature Biotechnology, 21, 41-46 (2003).
22. J. W. M. Bulte, T. Douglas, B. Witwer, S. C. Zhang, E. Strable, B. K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B. M. Moskowitz, I. D. Duncan, and J. A. Frank, "Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells," Nature Biotechnology, 19, 1141-1147 (2001).
23. W. C.W. Chan, D. J. Maxwell, X. H. Gao, R. E. Bailey, M. Y. Han, and S. M. Nie, "Luminescent quantum dots for multiplexed biological detection and imaging," Current Opinion in Biotechnology, 13, 40-46 (2002).
24. M. Lewin, N. Carlesso, C. H. Tung, X. W. Tang, D. Cory, D. T. Scadden, and R. Weissleder, "Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells," Nature Biotechnology, 18, 410-414 (2000).
25. M. Bailly, L. Yan, G. M. Whitesides, J. S. Condeelis, and J. E. Segall, "Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells," Experimental Cell Research, 241, 285-299, (1998).
26. Y.W. Cao, R. Jin, and C. A. Mirkin, "DNA-modified core-shellAg/Au nanoparticles," Journal of the American Chemical Society, 123, 7961- 7962, (2001).
27. X. H. Gao, W. C.W. Chan, and S. M. Nie, "Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding," Journal of Biomedical Optics, 7, 532-537 (2002).
28. J. T. Hu, T.W. Odom, and C. M. Lieber, "Chemistry and physics in one dimension: Synthesis and properties of nanowires and nanotubes," Accounts of Chemical Research, 32, 435-445 (1999).
29. G. MacBeath, "Protein microarrays and proteomics," Nature Genetics, 32, 526-532 (2002).
30. G. MacBeath, "Proteomics comes to the surface - Microarrays of purified proteins, representing most of the yeast genome, prove useful for studying protein function on a genome-wide scale," Nature Biotechnology, 19, 828-829 (2001).
31. G. MacBeath and S. L. Schreiber, "Printing proteins as microarrays for high-throughput function determination," Science, 289, 1760-1763 (2000).
32. G. MacBeath, A. N. Koehler, and S. L. Schreiber, "Printing small molecules as microarrays and detecting protein-ligand interactions en masse," Journal of the American Chemical Society, 121, 7967-7968 (1999).
33. C. S. Chen, M. Mrksich, S. Huang, G. M. Whitesides, and D. E. Ingber, "Geometric control of cell life and death," Science, 276, 1425-1428 (1997).
34. M. Mrksich, "Tailored substrates for studies of attached cell culture," Cellular and Molecular Life Sciences, 54, 653-662 (1998).
35. N. Sniadecki, R.A. Desai, S.A. Ruiz, and C. S. Chen, "Nanotechnology for cell-substrate interactions," Annals of Biomedical Engineering, 34, 59-74 (2006).
36. Y. S. Lee and M. Mrksich, "Protein chips: from concept to practice," Trends in Biotechnology, 20, S14-S18 (2002).
37. B. D. Gates, Q. B. Xu, J. C. Love, D. B. Wolfe, and G. M. Whitesides, "Unconventional nanofabrication," Annual Review of Materials Research, 34, 339-372 (2004).
38. B. D. Gates, Q. B. Xu, M. Stewart, D. Ryan, C. G. Willson, and G. M. Whitesides, "New approaches to nanofabrication: Molding, printing, and other techniques," Chemical Reviews, 105, 1171-1196 (2005).
39. M. Mrksich and G.M. Whitesides, "Using self-assembled monolayers to understand the interactions of man-made surfaces with proteins and cells," Annual Review of Biophysics and Biomolecular Structure, 25, 55-78 (1996).
40. D. Qin, Y. N. Xia, J. A. Rogers, R. J. Jackman, X. M. Zhao, and G. M. Whitesides, "Microfabrication, microstructures and microsystems," Microsystem Technology in Chemistry and Life Science, 194, 1-20 (1998).
41. D. B. Weibel, P. Garstecki, and G. M. Whitesides, "Combining microscience and neurobiology," Current Opinion in Neurobiology, 15, 560-567 (2005).
42. G. M. Whitesides, E. Ostuni, S. Takayama, X.Y. Jiang, and D. E. Ingber, "Soft lithography in biology and biochemistry," Annual Review of Biomedical Engineering, 3, 335-373 (2001).
43. Y. N. Xia, J. A. Rogers, K. E. Paul, and G. M. Whitesides, "Unconventional methods for fabricating and patterning nanostructures," Chemical Reviews, 99, 1823-1848 (1999).
44. Y. N. Xia and G. M. Whitesides, "Soft lithography," Angewandte Chemie-International Edition, 37, 551-575 (1998).
45. G. Y. Liu, S. Xu, and Y. L. Qian, "Nanofabrication of self-assembled monolayers using scanning probe lithography," Accounts of Chemical Research, 33, 457-466 (2000).
46. D. Wouters and U. S. Schubert, "Nanolithography and nanochemistry: Probe-related patterning techniques and chemical modification for nanometer-sized devices," Angewandte Chemie-International Edition, 43, 2480-2495 (2004).
47. K. Salaita, Y. H. Wang, and C. A. Mirkin, "Applications of dip-pen nanolithography," Nature Nanotechnology, 2, 145-155 (2007).
48. J. Loos, "The art of SPM: Scanning probe microscopy in materials science," Advanced Materials, 17, 1821-1833 (2005).
49. Q. Tang, S. Q. Shi, and L. M. Zhou, "Nanofabrication with atomic force microscopy," Journal of Nanoscience and Nanotechnology, 4, 948- 963 (2004).
50. D. Wouters and U. S. Schubert, "Nanolithography and nanochemistry: Probe-related patterning techniques and chemical modification for nanometer-sized devices," Angewandte Chemie-International Edition, 43, 2480-2495 (2004).
51. S. H. Hong, J. Zhu, and C. A. Mirkin, "Multiple ink nanolithography: Toward a multiple-pen nano-plotter," Science, 286, 523-525 (1999).
52. R. D. Piner, J. Zhu, F. Xu, S. H. Hong, and C. A. Mirkin, "Dip-pen nanolithography," Science, 283, 661-663 (1999).
53. E. Katz and I. Willner, "Integrated nanoparticle-biomolecule hybrid systems: Synthesis, properties, and applications," Angewandte Chemie-International Edition, 43, 6042-6108, (2004).
54. H. W. Liao, C. L. Nehl, and J. H. Hafner, "Biomedical applications of plasmon resonant metal nanoparticles," Nanomedicine, 1, 201-208 (2006).
55. F. Hyafil, J. C. Cornily, J. E. Feig, R. Gordon, E. Vucic, V. Amirbekian, E. A. Fisher, V. Fuster, L. J. Feldman, and Z. A. Fayad, "Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography," Nature Medicine, 13, 636-641 (2007).
56. J. M. Karp and R. Langer, "Development and therapeutic applications of advanced biomaterials," Current Opinion in Biotechnology, 18, 454- 459 (2007).
57. R. Langer and D. A. Tirrell, "Designing materials for biology and medicine," Nature, 428, 487-492 (2004).
58. D. A. LaVan, T. McGuire, and R. Langer, "Small-scale systems for in vivo drug delivery," Nature Biotechnology, 21, 1184-1191 (2003).
59. S. J. Son, X. Bai, and S. Lee, "Inorganic hollow nanoparticles and nanotubes in nanomedicine. Part 2: Imaging, diagnostic, and therapeutic applications," Drug Discovery Today, 12, 657-663 (2007).
60. W. W. Wu and A. D. Li, "Optically switchable nanoparticles for biological imaging," Nanomedicine, 2, 523-531 (2007).
61. Q. L. de Chermont, C. Chaneac, J. Seguin, F. Pelle, S. Maitrejean, J. P. Jolivet, D. Gourier, M. Bessodes, and D. Scherman, "Nanoprobes with near-infrared persistent luminescence for in vivo imaging," Proceedings of the National Academy of Sciences of the United States of America, 104, 9266-9271 (2007).
62. X. H. Gao, L. L. Yang, J. A. Petros, F. F. Marshal, J. W. Simons, and S. M. Nie, "In vivo molecular and cellular imaging with quantum dots," Current Opinion in Biotechnology, 16, 63-72, (2005).
63. X. Michalet, F. F. Pinaud, L. A. Bentolila, J. M. Tsay, S. Doose, J. J. Li, G. Sundaresan, A. M. Wu, S. S. Gambhir, and S. Weiss, "Quantum dots for live cells, in vivo imaging, and diagnostics," Science, 307, 538-544 (2005).
64. S. M. Nie, Y. Xing, G. J. Kim, and J. W. Simons, "Nanotechnology applications in cancer," Annual Review of Biomedical Engineering, 9, 257-288 (2007).
65. M. N. Rhyner, A. M. Smith, X. H. Gao, H. Mao, L. L. Yang, and S. M. Nie, "Quantum dots and multifunctional nanoparticles: New contrast agents for tumor imaging," Nanomedicine, 1, 209-217 (2006).
66. M. Stroh, J. P. Zimmer, D. G. Duda, T. S. Levchenko, K. S. Cohen, E. B. Brown, D. T. Scadden, V. P. Torchilin, M. G. Bawendi, D. Fukumura, and R. K. Jain, "Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo," Nature Medicine, 11, 678-682 (2005).
67. R. E. Bailey and S. M. Nie, "Alloyed semiconductor quantum dots: Tuning the optical properties without changing the particle size," Journal of the American Chemical Society, 125, 7100-7106, (2003).
68. S. J. Rosenthal, J. McBride, S. J. Pennycook, and L. C. Feldman, "Synthesis, surface studies, composition and structural characterization of CdSe, core/shell and biologically active nanocrystals," Surface Science Reports, 62, 111-157, (2007).
69. D. S. Wang, J. B. He, N. Rosenzweig, and Z. Rosenzweig, "Superparamagnetic Fe2O3 Beads-CdSe/ZnS quantum dots core-shell nanocomposite particles for cell separation," Nano Letters, 4, 409-413 (2004).
70. Y. Yin and A. P. Alivisatos, "Colloidal nanocrystal synthesis and the organic-inorganic interface," Nature, 437, 664-670, (2005).
71. E. L. Bentzen, F. House, T. J. Utley, J. E. Crowe, and D. W. Wright, "Progression of respiratory syncytial virus infection monitored by fluorescent quantum dot probes," Nano Letters, 5, 591-595 (2005).
72. T. Jamieson, R. Bakhshi, D. Petrova, R. Pocock, M. Imani, and A. M. Seifalian, "Biological applications of quantum dots," Biomaterials, 28, 4717-4732 (2007).
73. B. I. Ipe, M. Lehnig, and C. M. Niemeyer, "On the generation of free radical species from quantum dots," Small, 1, 706-709 (2005).
74. C. Kirchner, T. Liedl, S. Kudera, T. Pellegrino, A. M. Javier, H. E. Gaub, S. Stolzle, N. Fertig, and W. J. Parak, "Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles," Nano Letters, 5, 331-338 (2005).
75. A. M. Derfus, W. C.W. Chan, and S. N. Bhatia, "Probing the cytotoxicity of semiconductor quantum dots," Nano Letters, 4, 11-18 (2004).
76. A. Hoshino, K. Fujioka, T. Oku, M. Suga, Y. F. Sasaki, T. Ohta, M. Yasuhara, K. Suzuki, and K. Yamamoto, "Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification," Nano Letters, 4, 2163-2169, 2004.
77. S. Link and M. A. El-Sayed, "Optical properties and ultrafast dynamics of metallic nanocrystals" Annual Review of Physical Chemistry, 54, 331-366 (2003).
78. P. K. Jain, I. H. El-Sayed, and M.A. El-Sayed, "Au nanoparticles target cancer," Nano Today, 2, 18-29 (2007).
79. E. E. Connor, J. Mwamuka, A. Gole, C. J. Murphy, and M. D. Wyatt, "Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity," Small, 1, 325-327 (2005).
80. C. M. Niemeyer and B. Ceyhan, "DNA-directed functionalization of colloidal gold with proteins," Angewandte Chemie-International Edition, 40, 3685-+ (2001).
81. R. Bhattacharya, C. R. Patra, A. Earl, S. F. Wang, A. Katarya, L. C. Lu, J. N. Kizhakkedathu, M. J. Yaszemski, P. R. Greipp, D. Mukhopadhyay, and P. Mukherjee, "Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells," Nanomedicine, 3, 224-238 (2007).
82. V. Dixit, J. Van den Bossche, D. M. Sherman, D. H. Thompson, and R. P. Andres, "Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells," Bioconjugate Chemistry, 17, 603-609 (2006).
83. B. D. Chithrani and W. C. W. Chan, "Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes," Nano Letters, 7, 1542-1550 (2007).
84. P. H. Yang, X. S. Sun, J. F. Chiu, H. Z. Sun, and Q. Y. He, "Transferrinmediated gold nanoparticle cellular uptake," Bioconjugate Chemistry, 16, 494-496 (2005).
85. K. Sokolov, D. Nida, M. Descour, A. Lacy, M. Levy, B. Hall, S. Dharmawardhane, A. Ellington, B. Korgel, and R. Richards- Kortum, "Molecular optical imaging of therapeutic targets of cancer," Advances in Cancer Research, 96, 299-344, 2007.
86. G. F. Zheng, F. Patolsky, Y. Cui, W. U. Wang, and C. M. Lieber, "Multiplexed electrical detection of cancer markers with nanowire sensor arrays," Nature Biotechnology, 23, 1294-1301, 2005.
87. R. J. Chen, S. Bangsaruntip, K.A. Drouvalakis, N.W. S. Kam, M. Shim, Y. M. Li, W. Kim, P. J. Utz, and H. J. Dai, "Noncovalent functionalization of carbon nanotubes for highly specific electronic biosensors," Proceedings of the National Academy of Sciences of the United States of America, 100, 4984-4989 (2003).
88. S. D. Caruthers, S. A. Wickline, and G. M. Lanza, "Nanotechnological applications in medicine," Current Opinion in Biotechnology, 18, 26-30 (2007).
89. C. Corot, P. Robert, J. M. Idee, and M. Port, "Recent advances in iron oxide nanocrystal technology for medical imaging," Advanced Drug Delivery Reviews, 58, 1471-1504 (2006).
90. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications," Biomaterials, 26, 3995-4021 (2005).
91. Y. E. L. Koo, G. R. Reddy, M. Bhojani, R. Schneider, M.A. Philbert, A. Rehemtulla, B. D. Ross, and R. Kopelman, "Brain cancer diagnosis and therapy with nanoplatforms," Advanced Drug Delivery Reviews, 58, 1556-1577 (2006).
92. J. K. Raty, T. Liimatainen, M. U. Kaikkonen, O. Grahn, K. J. Airenne, and S. Yla-Herttuala, "Non-invasive Imaging in gene therapy," Molecular Therapy, 15, 1579-1586 (2007).
93. W. J. Rogers, C. H. Meyer, and C. M. Kramer, "Technology insight: in vivo cell tracking by use of MRI," Nature Clinical Practice Cardiovascular Medicine, 3, 554-562 (2006).
94. D. L. J. Thorek, A. Chen, J. Czupryna, and A. Tsourkas, "Superparamagnetic iron oxide nanoparticle probes for molecular imaging," Annals of Biomedical Engineering, 34, 23-38 (2006).
95. W. A. Weber, J. Czernin, M. E. Phelps, and H. R. Herschman, "Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs," Nature Clinical Practice Oncology, 5, 44-54 (2008).
96. Y. M. Huh, Y.W. Jun, H. T. Song, S. Kim, J. S. Choi, J. H. Lee, S. Yoon, K. S. Kim, J. S. Shin, J. S. Suh, and J. Cheon, "In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals," Journal of the American Chemical Society, 127, 12387-12391 (2005).
97. Y.W. Jun, Y. M. Huh, J. S. Choi, J. H. Lee, H. T. Song, S. Kim, S. Yoon, K. S. Kim, J. S. Shin, J. S. Suh, and J. Cheon, "Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging," Journal of the American Chemical Society, 127, 5732-5733 (2005).
98. J. H. Lee, Y. M. Huh, Y. Jun, J. Seo, J. Jang, H. T. Song, S. Kim, E. J. Cho, H. G. Yoon, J. S. Suh, and J. Cheon, "Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging," Nature Medicine, 13, 95-99 (2007).
99. H. T. Song, J. S. Choi, Y. M. Huh, S. Kim, Y. W. Jun, J. S. Suh, and J. Cheon, "Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling," Journal of the American Chemical Society, 127, 9992-9993 (2005).
100. T. M. Allen and F. J. Martin, "Advantages of liposomal delivery systems for anthracyclines," Seminars in Oncology, 31, 5-15 (2004).
101. L. Cattel, M. Ceruti, and F. Dosio, "From conventional to stealth liposomes a new frontier in cancer chemotherapy," Tumori, 89, 237-249 (2003).
102. J. A. Sparano and E. P. Winer, "Liposomal anthracyclines for breast cancer," Seminars in Oncology, 28, 32-40 (2001).
103. A. Gabizon, H. Shmeeda, and Y. Barenholz, "Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies," Clinical Pharmacokinetics, 42, 419-436, 2003.
104. N. E. Hynes and H. A. Lane, "ERBB receptors and cancer: The complexity of targeted inhibitors," Nature Reviews Cancer, 5, 341-354 (2005).
105. R. Duncan, M. J. Vicent, F. Greco, and R. I. Nicholson, "Polymerdrug conjugates: Towards a novel approach for the treatment of endrocine-related cancer," Endocrine-Related Cancer, 12, S189-S199 (2005).
106. P. D. Senter and C. J. Springer, "Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates," Advanced Drug Delivery Reviews, 53, 247-264 (2001).
107. J. E. Dancey and H. X. Chen, "Strategies for optimizing combinations of molecularly targeted anticancer agents," Nature Reviews Drug Discovery, 5, 649-659 (2006).
108. K. Imai and A. Takaoka, "Comparing antibody and small-molecule therapies for cancer," Nature Reviews Cancer, 6, 714-727 (2006).
109. S. A. Marshall, G. A. Lazar, A. J. Chirino, and J. R. Desjarlais, "Rational design and engineering of therapeutic proteins," Drug Discovery Today, 8, 212-221 (2003).
110. L. Brannon-Peppas and J. O. Blanchette, "Nanoparticle and targeted systems for cancer therapy," Advanced Drug Delivery Reviews, 56, 1649-1659 (2004).
111. D. Peer, J. M. Karp, S. Hong, O. C. FaroKhzad, R. Margalit, and R. Langer, "Nanocarriers as an emerging platform for cancer therapy," Nature Nanotechnology, 2, 751-760 (2007).
112. I. Brigger, C. Dubernet, and P. Couvreur, "Nanoparticles in cancer therapy and diagnosis," Advanced Drug Delivery Reviews, 54, 631-651 (2002).
113. T. M. Allen, "The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system," Advanced Drug Delivery Reviews, 13, 285-309 (1994).
114. G. J. Kim and a. S. Nie, "Targeted cancer nanotherapy," nanotoday, 8, 28-33 (2005).
115. J.W. Park, D. B. Kirpotin, K. Hong, R. Shalaby, Y. Shao, U. B. Nielsen, J. D. Marks, D. Papahadjopoulos, and C. C. Benz, "Tumor targeting using anti-her2 immunoliposomes," Journal of Controlled Release, 74, 95-113 (2001).
116. V. P. Torchilin, "Multifunctional nanocarriers," Advanced Drug Delivery Reviews, 58, 1532-1555 (2006).
117. S. M. Moghimi, A. C. Hunter, and J. C. Murray, "Nanomedicine: current status and future prospects," Faseb Journal, 19, 311-330 (2005).
118. T. Betancourt, B. Brown, and L. Brannon-Peppas, "Doxorubicinloaded PLGAnanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation," Nanomedicine, 2, 219-232 (2007).
119. W. J. Duncanson, M. A. Figa, K. Hallock, S. Zalipsky, J. A. Hamilton, and J. Y. Wong, "Targeted binding of PLA microparticles with lipid- PEG-tethered ligands," Biomaterials, 28, 4991-4999 (2007).
120. J. Panyam and V. Labhasetwar, "Biodegradable nanoparticles for drug and gene delivery to cells and tissue," Advanced Drug Delivery Reviews, 55, 329-347 (2003).
121. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, "Biodegradable polymeric nanoparticles as drug delivery devices," Journal of Controlled Release, 70, 1-20 (2001).
122. J. K. Vasir and V. Labhasetwar, "Biodegradable nanoparticles for cytosolic delivery of therapeutics," Advanced Drug Delivery Reviews, 59, 718-728 (2007).
123. J. M. Dang and K. W. Leong, "Natural polymers for gene delivery and tissue engineering," Advanced Drug Delivery Reviews, 58, 487-499 (2006).
124. A. des Rieux, V. Fievez, M. Garinot, Y. J. Schneider, and V. Preat, "Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach," Journal of Controlled Release, 116, 1-27 (2006).
125. Y. J. Liu, Y. L. Li, S. C. Liu, J. Li, and S. Z. Yao, "Monitoring the selfassembly of chitosan/glutaraldehyde/cysteamine/Au-colloid and the binding of human serum albumin with hesperidin," Biomaterials, 25, 5725-5733 (2004).
126. N. A. Peppas, J. Z. Hilt, A. Khademhosseini, and R. Langer, "Hydrogels in biology and medicine: From molecular principles to bionanotechnology," Advanced Materials, 18, 1345-1360 (2006).
127. G. Gaucher, M. H. Dufresne, V. P. Sant, N. Kang, D. Maysinger, and J. C. Leroux, "Block copolymer micelles: preparation, characterization and application in drug delivery," Journal of Controlled Release, 109, 169-188 (2005).
128. M. C. Jones, M. Ranger, and J. C. Leroux, "pH-sensitive unimolecular polymeric micelles: Synthesis of a novel drug carrier," Bioconjugate Chemistry, 14, 774-781 (2003).
129. E. S. Lee, K. T. Oh, D. Kim, Y. S. Youn, and Y. H. Bae, "Tumor pHresponsive flower-like micelles of poly(L-lactic acid)-b-poly (ethylene glycol)-b-poly(L-histidine)," Journal of Controlled Release, 123, 19-26 (2007).
130. W. J. Lin, L. W. Juang, and C. C. Lin, "Stability and release performance of a series of pegylated copolymeric micelles," Pharmaceutical Research, 20, 668-673 (2003).
131. W.Y. Seow, J.M. Xue, andY.Y. Yang, "Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles," Biomaterials, 28, 1730-1740 (2007).
132. X. L. Wang, R. Jensen, and Z. R. Lu, "A novel environment-sensitive biodegradable polydisulfide with protonatable pendants for nucleic acid delivery," Journal of Controlled Release, 120, 250-258 (2007).
133. F. L. Mi, Y. Y. Wu, Y. L. Chiu, M. C. Chen, H. W. Sung, S. H. Yu, S. S. Shyu, and M. F. Huang, "Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells," Biomacromolecules, 8, 892-898 (2007).
134. T. A. Elbayoumi, S. Pabba, A. Roby, and V. P. Torchilin, "Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents," Journal of Liposome Research, 17, 1-14, 2007.
135. F. Lacoeuille, F. Hindre, F. Moal, J. Roux, C. Passirani, O. Couturier, P. Cales, J. J. Le Jeune, A. Lamprecht, and J. P. Benoit, "In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel," International Journal of Pharmaceutics, 344, 143-149 (2007).
136. J. C. Leroux, "Injectable nanocarriers for biodetoxification," Nature Nanotechnology, 2, 679-684 (2007).
137. T. Lian and R. J. Y. Ho, "Trends and developments in liposome drug delivery systems," Journal of Pharmaceutical Sciences, 90, 667-680 (2001).
138. S. M. Moghimi and S. S. Davis, "Innovations in avoiding particle clearance from blood by kupffer cells-cause for reflection," Critical Reviews in Therapeutic Drug Carrier Systems, 11, 31-59 (1994).
139. S. Y. Cho and H. R. Allcock, "Dendrimers derived from polyphosphazene- poly(propyleneimine) systems: Encapsulation and triggered release of hydrophobic guest molecules," Macromolecules, 40, 3115-3121 (2007).
140. C. M. Paleos, D. Tsiourvas and Z. Sideratou, "Molecular engineering of dendritic polymers and their application as drug and gene delivery systems," Molecular Pharmaceutics, 4, 169-188 (2007).
141. F. P. Seib, A. T. Jones and R. Duncan, "Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells," Journal of Controlled Release, 117, 291-300 (2007).
142. X. G. Shi, S. H. Wang, S. Meshinchi, M. E. Van Antwerp, X. D. Bi, I. H. Lee and J. R. Baker, "Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and Imaging," Small, 3, 1245-1252 (2007).
143. J. F. Kukowska-Latallo, K. A. Candido, Z. Y. Cao, S. S. Nigavekar, I. J. Majoros, T. P. Thomas, L. P. Balogh, M. K. Khan and J. R. Baker, "Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer," Cancer Research, 65, 5317-5324 (2005).
144. A. L. Crumbliss, S. C. Perine, J. Stonehuerner, K.R. Tubergen, Junguo Zhao, R. W. Henkens and J. P. O'Daly, "Colloidal gold as a biocompatible immobilization matrix suitable for the fabrication of enzyme electrodes by electrodeposition," Biotechnology and Bioengineering, 40, 483-490 (2004).
145. T. B. Huff, M.N. Hansen, Y. Zhao, J. X. Cheng andA. Wei, "Controlling the cellular uptake of gold nanorods," Langmuir, 23, 1596-1599 (2007).
146. J. Kneipp, H. Kneipp, M. McLaughlin, D. Brown and K. Kneipp, "In vivo molecular probing of cellular compartments with gold nanoparticles and nanoaggregates," Nano Letters, 6, 2225-2231, 2006.
147. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde and M. Sastry, "Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment:Amicroscopic overview," Langmuir, 21, 10644-10654 (2005).
148. Paciotti GF, Meyer L, Weinreich D, Goia D, Pavel N, M. RE and a. T. L, "Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery.," Drug Delivery, 11, 169-183 (2004).
149. N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. Hanand C.A. Mirkin, "Oligonucleotide-modified gold nanoparticles for intracellular gene regulation," Science, 312, 1027-1030 (2006).
150. T. Neuberger, B. Schopf, H. Hofmann, M. Hofmann and B. von Rechenberg, "Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system," Journal of Magnetism and Magnetic Materials, 293, 483-496 (2005).
151. D. E. Sosnovik and R. Weissleder, "Emerging concepts in molecular MRI," Current Opinion in Biotechnology, 18, 4-10, 2007.
152. I. Garcia, N. E. Zafeiropoulos, A. Janke, A. Tercjak, A. Eceiza, M. Stamm and I. Mondragon, "Functional ization of iron oxide magnetic nanoparticles with poly(methyl methacrylate) brushes via graftingfrom atom transfer radical polymerization," Journal of Polymer Science Part a-Polymer Chemistry, 45, 925-932, 2007.
153. M. Lattuada and T. A. Hatton, "Functionalization of monodisperse magnetic nanoparticles," Langmuir, 23, 2158-2168, 2007.
154. I. H. El-Sayed, X. H. Huang and M. A. El-Sayed, "Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles," Cancer Letters, 239, 129-135 (2006).
155. M. Everts, V. Saini, J. L. Leddon, R. J. Kok, M. Stoff-Khalili, M. A. Preuss, C. L. Millican, G. Perkins, J. M. Brown, H. Bagaria, D. E. Nikles, D. T. Johnson, V. P. Zharov and D. T. Curiel, "Covalently linked au nanoparticles to a viral vector: Potential for combined photothermal and gene cancer therapy," Nano Letters, 6, 587-591 (2006).
156. X. H. Huang, I. H. El-Sayed, W. Qian and M. A. El-Sayed, "Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods," Journal of the American Chemical Society, 128, 2115-2120 (2006).
157. W. S. Seo, J. H. Lee, X. M. Sun, Y. Suzuki, D. Mann, Z. Liu, M. Terashima, P. C. Yang, M. V. McConnell, D. G. Nishimura and H. J. Dai, "FeCo/graphitic-shell nanocrystals as advanced magneticresonance- imaging and near-infrared agents," Nature Materials, 5, 971-976 (2006).
158. V. P. Zharov, K. E. Mercer, E. N. Galitovskaya and M. S. Smeltzer, "Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles," Biophysical Journal, 90, 619-627 (2006).
159. C. P. Barham, R. L. Jones, L. R. Biddlestone, R. H. Hardwick, N. A. Shepherd and H. Barr, "Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation," Gut, 41, 281-284 (1997).
160. J. Y. Chen, D. L. Wang, J. F. Xi, L. Au, A. Siekkinen, A. Warsen, Z. Y. Li, H. Zhang, Y. N. Xia and X. D. Li, "Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells," Nano Letters, 7, 1318-1322 (2007).
161. C. Loo, A. Lowery, N. Halas, J. West and R. Drezek, "Immunotargeted nanoshells for integrated cancer imaging and therapy," Nano Letters, 5, 709-711 (2005).
162. R. F. Ismagilov and M. M. Maharbiz, "Can we bufld synthetic, mullficeflullar systems by controfflng developmental signaflng in space and time?," Current Opinion in Chemical Biology, 11, 604-611 (2007).
163. P. S. Dittrich and A. Manz, "Lab-on-a-chip: microfluidics in drug discovery," Nature Reviews Drug Discovery, 5, 210-218 (2006).
164. P. S. Dittrich, K. Tachikawa and A. Manz, "Micro total analysis systems. Latest advancements and trends," Analytical Chemistry, 78, 3887-3907 (2006).
165. J. El-Ali, P. K. Sorger and K. F. Jensen, "Cells on chips," Nature, 442, 403-411 (2006).
166. D. Falconnet, G. Csucs, H. M. Grandin and M. Textor, "Surface engineering approaches to micropattern surfaces for cell-based assays," Biomaterials, 27, 3044-3063 (2006).
167. A. Khademhosseini, R. Langer, J. Borenstein and J. P. Vacanti, "Microscale technologies for tissue engineering and biology," Proceedings of the National Academy of Sciences of the United States of America, 103, 2480-2487 (2006).
168. S. Nagrath, L. V. Sequist, S. Maheswaran, D. W. Bell, D. Irimia, L. Ulkus, M. R. Smith, E. L. Kwak, S. Digumarthy, A. Muzikansky, P. Ryan, U. J. Balis, R. G. Tompkins, D. A. Haber and M. Toner, "Isolation of rare circulating tumour cells in cancer patients by microchip technology," Nature, 450, 1235-U10 (2007).
169. P. Moore, "Cell biology: Ion channels and stem cells," Nature, 438, 699-704 (2005).
170. S. K.W. Dertinger, X. Y. Jiang, Z. Y. Li, V. N. Murthy and G. M. Whitesides, "Gradients of substrate-bound laminin orient axonal specification of neurons," Proceedings of the National Academy of Sciences of the United States of America, 99, 12542-12547 (2002).
171. F. K. Balagadde, L. C. You, C. L. Hansen, F. H. Arnold and S. R. Quake, "Long-term monitoring of bacteria undergoing programmed population control in a microchemostat," Science, 309, 137-140 (2005).
172. G. Martino and S. Pluchino, "The therapeutic potential of neural stem cells," Nature Reviews Neuroscience, 7, 395-406 (2006).
173. S. Temple, "The development of neural stem cells," Nature, 414, 112- 117 (2001).
174. E. Fuchs, T. Tumbar and G. Guasch, "Socializing with the neighbors: Stem cells and their niche," Cell, 116, 769-778 (2004).
175. K. A. Moore and I. R. Lemischka, "Stem cells and their niches," Science, 311, 1880-1885 (2006).
176. I. Kratchmarova, B. Blagoev, M. Haack-Sorensen, M. Kassem and M. Mann, "Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation," Science, 308, 1472-1477 (2005).
177. M. P. Lutolf and J. A. Hubbell, "Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering," Nature Biotechnology, 23, 47-55 (2005).
178. F. M. Watt and B. L. M. Hogan, "Out of Eden: Stem cells and their niches," Science, 287, 1427-1430 (2000).
179. T. P. Fleming, B. Sheth and I. Fesenko, "Cell adhesion in the preimplantation mammalian embryo and its role in trophectoderm differentiation and blastocyst morphogenesis," Frontiers in Bioscience, 6, D1000-D1007 (2001).
180. M. C. Yoder and D. A. Williams, "Matrix molecule interactions with hematopoietic stem-cells," Experimental Hematology, 23, 961-967 (1995).
181. S. Ding and P. G. Schultz, "A role for chemistry in stem cell biology," Nat Biotech, 22, 833-840 (2004).
182. C. J. Flaim, S. Chien and S. N. Bhatia, "An extracellular matrix microarray for probing cellular differentiation," Nature Methods, 2, 119-125 (2005).
183. Y. Soen, A. Mori, T. D. Palmer and P. O. Brown, "Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments," Molecular Systems Biology, (2006).